News + Filings Transactions Holdings
All 13F 13D/G Other
|
AJJARAPU SURENDRA K
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/12/2023 |
4
| AJJARAPU SURENDRA K (CEO and Chairman) has filed a Form 4 on Semper Paratus Acquisition Corp
Txns:
| Granted 1,000,000 shares
@ $0 Granted 7,988,889 options to buy
@ $0 Granted 500,000 options to buy
@ $11.5, valued at
$5.8M
|
|
03/24/2023 |
4
| AJJARAPU SURENDRA K (Director) has filed a Form 4 on Ocean Biomedical, Inc.
Txns:
| Disposed of 1,050,000 shares
@ $0 |
|
03/02/2023 |
4
| AJJARAPU SURENDRA K (10% Owner) has filed a Form 4 on Ocean Biomedical, Inc.
Txns:
| Disposed of 2,625,000 shares
@ $0 Acquired 469,300 shares
@ $0 Acquired 258,200 shares
@ $0 Bought 5,411,000 options to buy
@ $1, valued at
$5.4M
Disposed of 5,411,000 options to buy
@ $11.5, valued at
$62.2M
Acquired 5,411,000 options to buy
@ $11.5, valued at
$62.2M
Disposed of 5,411,000 options to buy
@ $11.5, valued at
$62.2M
Acquired 1,291,000 options to buy
@ $11.5, valued at
$14.8M
|
|
09/16/2022 |
4
| AJJARAPU SURENDRA K (CEO) has filed a Form 4 on TRxADE HEALTH, INC
Txns:
| Granted 51,724 shares
@ $0 |
|
05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2021 |
4
| AJJARAPU SURENDRA K (CEO) has filed a Form 4 on Aesther Healthcare Acquisition Corp.
Txns:
| Disposed of 250,000 options to buy
@ $0 |
|
06/16/2020 |
4
| AJJARAPU SURENDRA K (CEO) has filed a Form 4 on TRXADE GROUP, INC.
Txns:
| Disposed of 201,613 shares
@ $0 |
|
04/15/2020 |
4
| AJJARAPU SURENDRA K (CEO) has filed a Form 4 on TRXADE GROUP, INC.
Txns:
| Granted 74,484 shares
@ $6.12, valued at
$455.8k
Granted 49,020 shares
@ $6.12, valued at
$300k
|
|
05/14/2019 |
4
| AJJARAPU SURENDRA K (CEO) has filed a Form 4 on TRXADE GROUP, INC.
Txns:
| Granted 100,000 options
@ $0.44, valued at
$44k
|
|
02/12/2018 |
4
| AJJARAPU SURENDRA K (CEO) has filed a Form 4 on TRXADE GROUP, INC.
Txns:
| Sold 250,000 shares
@ $112500, valued at
$28125M
|
|
04/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|